Intense Pulsed Light Treatment for Patients with Mild to Severe Meibomian Gland Dysfunction

The post-treatment response rate for patients with meibomian gland dysfunction (MGD) stage 2-3 was 64.3-66.7%.

• Both IPL Group1 and Self-hygiene Group showed improvements in meibomian gland functions and ocular surface disease index.
• No significant differences were observed in the improvements between the two groups for MGD stage 2-3.
• In patients with MGD stage 3-4, combining meibomian gland expression with IPL treatment led to a higher response rate of 75.5% compared to 63.3% in IPL Group2.
• Improvements in meibomian gland functions and ocular surface disease index were not statistically different across various ages, genders, and IPL energy exposure.
• Patients with higher Fitzpatrick skin types demonstrated greater improvements in meibomian gland expressibility.

Simplified